Latest filing published 13 Jun 2023 for Emergent BioSolutions Inc..
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +35.6%Entry US$32.23 · Close at T+365 US$43.71
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Adam Havey: trading record in brief
Adam Havey, listed as chief executive, appears in our data through filings on Emergent BioSolutions Inc. shares, published by SEC (Form 4). We count 129 filings; the first trade dates from 8 March 2011 and the latest from 9 June 2023.
In open-market terms, that means 1 purchase worth €2,430 on one side and 35 sales worth €11.3M on the other. Taken together, the sales exceed the purchases by €11.3M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 66 share grants and 23 option exercises.
On 13 June 2023 came the latest disclosure, a share grant in Emergent BioSolutions Inc. The most recent open-market purchase was published on 2 June 2015, 4,177 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Adam Havey
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 49,231 shares0Common StockSEC:0001367644-23-000121:1
- 24,616 shares0Common StockSEC:0001367644-23-000121:0
- 12,308 shares0Common StockSEC:0001367644-23-000072:1
- 6,154 shares0Common StockSEC:0001367644-23-000072:0
- 998 shares@ US$12.3835.0% of flowCommon StockSEC:0001367644-23-000054:0
- 812 shares@ US$13.710.1% of flowCommon StockSEC:0001367644-23-000033:1
- 432 shares@ US$14.3017.5% of flowCommon StockSEC:0001367644-23-000033:0
- 1,964 shares@ US$13.250.2% of flowCommon StockSEC:0001367644-23-000013:1
- 95 shares0Common StockSEC:0001367644-23-000013:0
- 17,822 shares0Common StockSEC:0001367644-22-000043:1
- 739 shares@ US$39.640.2% of flowCommon StockSEC:0001367644-22-000043:2
- 32,323 shares0Common StockSEC:0001367644-22-000043:0
- 828 shares@ US$42.470.2% of flowCommon StockSEC:0001367644-22-000030:1
- 424 shares@ US$42.2347.5% of flowCommon StockSEC:0001367644-22-000030:0
- 1,980 shares@ US$42.230.5% of flowCommon StockSEC:0001367644-22-000016:1
- 1,836 shares0Common StockSEC:0001367644-22-000016:0
- 17,134 shares@ US$30.633.1% of flowCommon StockSEC:0001367644-21-000049:0
- 17,134 shares@ US$99.6210.1% of flowCommon StockSEC:0001367644-21-000049:1
- 20,145 shares@ US$49.645.9% of flowCommon StockSEC:0001367644-21-000049:2
- 20,145 shares@ US$99.0211.8% of flowCommon StockSEC:0001367644-21-000049:3
- 847 shares@ US$93.490.5% of flowCommon StockSEC:0001367644-21-000047:2
- 739 shares@ US$97.150.4% of flowCommon StockSEC:0001367644-21-000047:3
- 732 shares@ US$97.150.4% of flowCommon StockSEC:0001367644-21-000047:4
- 3,744 shares0Common StockSEC:0001367644-21-000047:0
- 3,744 shares0Common StockSEC:0001367644-21-000047:1
25 of 128 declarations
